StockData

Mettler Toledo International vs Teradyne

MTD and TER side by side, both in laboratory apparatus and analytical, optical, measuring, and controlling instruments. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How MTD and TER compare

Teradyne is the larger company, worth 1.3 times as much as Mettler Toledo International ($42.9B against $33.6B).

On earnings, Teradyne is cheaper: it trades at 31.5× trailing earnings, against 37.7× for Mettler Toledo International.

Teradyne grew revenue faster over the last twelve months (74.9% versus 6.9% for Mettler Toledo International).

Teradyne keeps more of each dollar of sales as profit, with a net margin of 27.5% compared with 21.9% at Mettler Toledo International.

Teradyne pays a dividend yielding 0.19%; Mettler Toledo International does not pay one.

Teradyne scores higher on the StockData Score (20 against 10 for Mettler Toledo International), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricMTDTER
Size and price
Market cap$33.6B$42.9B
Share price$1674.81$274.37
Change, 1 year20.1%57.7%
Change, 5 years10.3%90.2%
Beta (5Y)1.161.62
Employees17K6,600
StockData Score
Total score1020 (better)
Valuation score13 (better)
Growth score33
Performance score35 (better)
Health score36 (better)
Dividend score03 (better)
Valuation
P/E37.7×31.5× (better)
P/S8.1× (better)8.6×
P/B2617×11.6× (better)
EV/EBITDA–24.3×
P/FCF38.8× (better)41.9×
PEG12.30–
FCF yield2.6% (better)2.4%
Fair value–$295.83
Margin of safety–7.3%
Growth
Revenue growth (TTM)6.9%74.9% (better)
Revenue growth, 5Y average5.5% (better)0.44%
Net income growth (TTM)9.1%210% (better)
EPS growth (TTM)12.5%217% (better)
EPS growth, 5Y average11.0% (better)−4.1%
Profitability
Gross margin60.3% (better)59.3%
Operating margin–32.1%
Net margin21.9%27.5% (better)
FCF margin20.9% (better)20.5%
Return on equity–42.9%
Return on invested capital–47.3%
Financial health
Debt / equity164.70 (better)0.00
Net debt / EBITDA–−0.26
Interest coverage–147×
Current ratio1.122.08 (better)
Altman Z-score10.3517.66 (better)
Piotroski F-score7 (better)6
Dividends and buybacks
Dividend yield–0.19%
Payout ratio–5.8%
Years of dividend growth–0
Dividend growth, 5Y average–3.7%
Buyback yield2.3% (better)0.83%
Shareholder yield2.3% (better)1.0%
Ownership
Held by institutions102%97.3%
Held by insiders0.37%0.25%
Insider net buying, 12 months−$35.9M−$14.1M (better)
Superinvestors holding11
Short interest, % of float3.5%5.5%

Go deeper

Other comparisons

For information only, not investment advice. Check the source filings before relying on any figure.